It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
A unique property of skeletal muscle is its ability to adapt its mass to changes in activity. Inactivity, as in disuse or aging, causes atrophy, the loss of muscle mass and strength, leading to physical incapacity and poor quality of life. Here, through a combination of transcriptomics and transgenesis, we identify sestrins, a family of stress-inducible metabolic regulators, as protective factors against muscle wasting. Sestrin expression decreases during inactivity and its genetic deficiency exacerbates muscle wasting; conversely, sestrin overexpression suffices to prevent atrophy. This protection occurs through mTORC1 inhibition, which upregulates autophagy, and AKT activation, which in turn inhibits FoxO-regulated ubiquitin–proteasome-mediated proteolysis. This study reveals sestrin as a central integrator of anabolic and degradative pathways preventing muscle wasting. Since sestrin also protected muscles against aging-induced atrophy, our findings have implications for sarcopenia.
Ageing is associated with muscle atrophy, which negatively impacts quality of life. Here the authors show that expression of sestrins decreases during inactivity and that their overexpression prevents atrophy in mice via modulation of autophagy and protein degradation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details


1 CIBERNED, Department of Experimental & Health Sciences, University Pompeu Fabra, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) ; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682)
2 CIBERNED, Department of Experimental & Health Sciences, University Pompeu Fabra, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427)
3 CIBERNED, Department of Experimental & Health Sciences, University Pompeu Fabra, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) ; Universidade de Lisboa, Instituto de Medicina Molecular (iMM), Faculdade de Medicina, Lisbon, Portugal (GRID:grid.9983.b) (ISNI:0000 0001 2181 4263)
4 Trinity College Dublin, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Dublin, Ireland (GRID:grid.8217.c) (ISNI:0000 0004 1936 9705) ; Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Moscow, Russia (GRID:grid.8217.c)
5 CIBERNED, Department of Experimental & Health Sciences, University Pompeu Fabra, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) ; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682) ; University Health Network, Princess Margaret Cancer Centre, Toronto, Canada (GRID:grid.231844.8) (ISNI:0000 0004 0474 0428)
6 University of Padova, Department of Biomedical Science, Padova, Italy (GRID:grid.5608.b) (ISNI:0000 0004 1757 3470)
7 Brigham Young University, Department of Physiology and Developmental Biology, Provo, USA (GRID:grid.253294.b) (ISNI:0000 0004 1936 9115)
8 University of California San Diego, Department of Pharmacology, La Jolla, USA (GRID:grid.266100.3) (ISNI:0000 0001 2107 4242)
9 University of Michigan, Department of Molecular and Integrative Physiology, Ann Arbor, USA (GRID:grid.214458.e) (ISNI:0000000086837370)
10 CIBERNED, Department of Experimental & Health Sciences, University Pompeu Fabra, Barcelona, Spain (GRID:grid.413448.e) (ISNI:0000 0000 9314 1427) ; Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain (GRID:grid.467824.b) (ISNI:0000 0001 0125 7682) ; ICREA, Barcelona, Spain (GRID:grid.425902.8) (ISNI:0000 0000 9601 989X)